
A Secondary Analysis of DANFLU-1 Trial - High vs Standard Dose Influenza Vaccine in CKD | ESC 2024
JACC This Week
00:00
Evaluating High Dose Influenza Vaccines in CKD Patients
This chapter explores a study comparing high dose influenza vaccines to standard doses, particularly for patients with chronic kidney disease. The findings indicate potential superior protection for CKD patients, leading to plans for a larger trial to further investigate these benefits.
Play episode from 05:33
Transcript


